Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–14 of 14 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT02945579
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
- Locations
-
- MD Anderson Cancer Center - Banner Gilbert, Arizona, United States
- Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
- Queen's Medical Center Honolulu, Hawaii, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT02654119
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +10 more
- Locations
-
- Faith Regional Health Services Carson Cancer Center Norfolk, Nebraska, United States
- Nebraska Medicine-Village Pointe Omaha, Nebraska, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT03387553
- Conditions
- Breast Cancer, Breast Cancer Female, Breast Cancer, Male, +12 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT03715959
- Conditions
- Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, +32 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT03530696
- Conditions
- Breast Cancer, Breast Cancer Stage, Breast Diseases, +9 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
- Cedar-Sinai Beverly Hills, California, United States
- University of Colorado Denver Aurora, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States
NCT02673398
- Conditions
- HER2 Positive Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7
- Locations
-
- City of Hope Corona Corona, California, United States
- City of Hope Medical Center Duarte, California, United States
- City of Hope Antelope Valley Lancaster, California, United States
- City of Hope Mission Hills Mission Hills, California, United States
NCT03364348
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +10 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States
NCT00005970
- Conditions
- Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Western Regional CCOP Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
NCT00684983
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +9 more
- Locations
-
- Providence Hospital Mobile, Alabama, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
- Mills-Peninsula Medical Center Burlingame, California, United States
NCT00390455
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive, +11 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Arroyo Grande Community Arroyo Grande, California, United States
- PCR Oncology Arroyo Grande, California, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
NCT04457596
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +4 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
NCT03384914
- Conditions
- Breast Cancer Female, Breast Cancer Stage I, Breast Cancer Stage II, +16 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory - Winship Cancer Institute Atlanta, Georgia, United States
- Indiana University - Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer
NCT03368729
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +5 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of Chicago Chicago, Illinois, United States
- Mayo Clinic Rochester, Minnesota, United States
- Montefiore The Bronx, New York, United States
Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer
NCT02827877
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +7 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States